Koichi Hagiwara

Gefitinib or Chemotherapy for Non–Small-Cell Lung Cancer with Mutated EGFR

Makoto Maemondo, Akira Inoue, Kunihiko Kobayashi et al. · New England Journal of Medicine · 2010 · 5.5K citations

Mutations of optineurin in amyotrophic lateral sclerosis

Hirofumi Maruyama, Hiroyuki Morino, Hidefumi Ito et al. · Nature · 2010 · 1.2K citations

Amyotrophic Lateral Sclerosis, Neurological Disorder, Neurology +4

Identification of angiogenic activity and the cloning and expression of platelet-derived endothelial cell growth factor

Fuyuki Ishikawa, Kohei Miyazono, Ulf Hellman et al. · Nature · 1989 · 715 citations

Thrombopoiesis, Thrombosis, Angiogenesis +10

Erlotinib plus bevacizumab versus erlotinib alone in patients with EGFR-positive advanced non-squamous non-small-cell lung cancer (NEJ026): interim analysis of an open-label, randomised, multicentre, phase 3 trial

Haruhiro Saito, Tatsuro Fukuhara, Naoki Furuya et al. · The Lancet Oncology · 2019 · 626 citations

Interim Analysis, Oncology, Bevacizumab Versus Erlotinib +8

Updated overall survival results from a randomized phase III trial comparing gefitinib with carboplatin–paclitaxel for chemo-naïve non-small cell lung cancer with sensitive EGFR gene mutations (NEJ002)

Akira Inoue, Kunihiko Kobayashi, Makoto Maemondo et al. · Annals of Oncology · 2012 · 549 citations

Oncology, Pathology, Cancer Treatment +6